{"id":"W2132037522","doi":"10.1016/j.lungcan.2004.11.029","title":"Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities—a multicenter phase II trial","year":2005,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Jewish General Hospital; Centre Hospitalier de l’Université de Montréal; Hôpital Charles-Le Moyne; McGill University; Royal Victoria Hospital","funders":"GlaxoSmithKline","keywords":"Vinorelbine; Gemcitabine; Medicine; Internal medicine; Lung cancer; Performance status; Population; Chemotherapy; Progressive disease; Oncology; Phases of clinical research; Antimetabolite; Gastroenterology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008342087,0.0005685647,0.000715105,0.0001887603,0.0002292113,0.00005780109,0.0001398914,0.00008222607,0.00106649],"category_scores_gemma":[0.000003846575,0.0003317468,0.00007747527,0.0004605467,0.0001169731,0.0004171538,0.0000274259,0.0003399153,0.000002884387],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001256388,"about_ca_system_score_gemma":0.001483464,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003455975,"about_ca_topic_score_gemma":0.005843234,"domain_scores_codex":[0.9973253,0.00005494796,0.0004967499,0.0006526001,0.0006402393,0.0008301465],"domain_scores_gemma":[0.9986459,0.00004255884,0.0003187429,0.0004156073,0.0002810604,0.0002961568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5602076,0.01014423,0.3861542,0.0006313078,0.002948204,0.000104948,0.0053406,0.001797813,0.0005319462,0.000002713651,0.007765789,0.02437061],"study_design_scores_gemma":[0.9117421,0.03695508,0.02247982,0.001593324,0.003409311,0.000006209549,0.0002559691,0.006046393,0.003683143,1.907748e-7,0.01283859,0.0009898982],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906203,0.002285484,0.0002709088,0.0004266368,0.0003138689,0.004998465,0.0005402888,0.00007162586,0.0004724756],"genre_scores_gemma":[0.9892527,0.0009282757,0.001374703,0.0007081727,0.0002739805,0.002159004,0.0005989457,0.0001340273,0.004570127],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3636744,"threshold_uncertainty_score":0.9999135,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01192527405406834,"score_gpt":0.3126804444621362,"score_spread":0.3007551704080679,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}